Home › Funds › SECTOR GAMMA AS › CRNX

SECTOR GAMMA AS position in CRNX

CRINETICS PHARMACEUTICALS IN

SECTOR GAMMA AS reported holding 114,628 shares of CRNX (CRINETICS PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$4.3M, representing 0.93% of its reported portfolio and ranking #34 among its reported holdings. SECTOR GAMMA AS has disclosed CRNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)114.63K sh
Reported value held$4.29M
Portfolio Weight0.93%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SECTOR GAMMA AS's CRNX position evolved

SECTOR GAMMA AS first disclosed a stake in CRNX in Q4 2025 at 115,000 shares (US$5.4M). Across 3 filings, SECTOR GAMMA AS increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 114,628 shares valued at US$4.3M — an increase of 20,433 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 115.00K $5.35M New
Q1 2026 94.19K $3.42M Reduce
Q2 2026 114.63K $4.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRNX and 13F data

CRNX (CRINETICS PHARMACEUTICALS IN) is a company whose sector is not yet classified in our data. 38 other funds we track also report a position in CRNX — the largest reported positions include Farallon Capital Management (US$336.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$336.4M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$241.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRNX

All CRNX fund holders →

FAQ

How long has SECTOR GAMMA AS held CRNX?

SECTOR GAMMA AS has disclosed CRNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SECTOR GAMMA AS's current position in CRNX?

As of Q2 2026, SECTOR GAMMA AS holds 114.63K shares of CRNX (CRINETICS PHARMACEUTICALS IN), valued at $4.29M, representing 0.93% of its reported portfolio and ranking #34.

Has SECTOR GAMMA AS been buying or selling CRNX?

In the latest 13F filing (Q2 2026), SECTOR GAMMA AS increased its position in CRNX.

Which other funds hold CRNX?

Other major institutional holders of CRNX include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., DRIEHAUS CAPITAL MANAGEMENT LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.